Results 161 to 170 of about 16,457 (219)
Cricopharyngeal Achalasia Leading to Recurrent Pneumonia and Failure to Thrive in an Infant: A Case Report. [PDF]
Respirol Case RepTafrishi R +3 more
europepmc +1 more source
Trends in management and healthcare resource utilization for achalasia following adoption of per-oral endoscopic myotomy. [PDF]
Surg EndoscRosenheck M +5 more
europepmc +1 more source
A Novel Endoscopic Finding of Achalasia: "Endoscopic Vertebrae Sign".
DigestionOchiai Y +5 more
europepmc +1 more source
Erratum: Thal Versus Nissen Fundoplication for the Management of Pediatric Gastroesophageal Reflux Disease: a Systematic Review and Meta-analysis: Erratum. [PDF]
Ann Med Surg (Lond)europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Gastroenterology Clinics of North America, 1989
Achalasia is a chronic illness that can be treated effectively in 65 to 90 per cent of patients with either pneumatic dilatation or Heller esophagomyotomy. Prior to institution of therapy, clinicians must rule out secondary achalasia, especially malignancy-associated achalasia, with upper endoscopy, and if the clinical history is worrisome for ...
J C, Reynolds, H P, Parkman
openaire +2 more sources
Achalasia is a chronic illness that can be treated effectively in 65 to 90 per cent of patients with either pneumatic dilatation or Heller esophagomyotomy. Prior to institution of therapy, clinicians must rule out secondary achalasia, especially malignancy-associated achalasia, with upper endoscopy, and if the clinical history is worrisome for ...
J C, Reynolds, H P, Parkman
openaire +2 more sources
Gastroenterology Clinics of North America, 2008
Achalasia is the best understood and most readily treatable esophageal motility disorder. It serves as a prototype for disorders of the enteric nervous system with degeneration of the myenteric neurons that innervate the lower esophageal sphincter (LES) and esophageal body.
Natasha, Walzer, Ikuo, Hirano
openaire +2 more sources
Achalasia is the best understood and most readily treatable esophageal motility disorder. It serves as a prototype for disorders of the enteric nervous system with degeneration of the myenteric neurons that innervate the lower esophageal sphincter (LES) and esophageal body.
Natasha, Walzer, Ikuo, Hirano
openaire +2 more sources
Gastrointestinal Endoscopy Clinics of North America, 2013
Endoscopic therapy for achalasia is centered on disrupting or weakening the lower esophageal sphincter. The three traditional treatment options for achalasia are surgical myotomy, pneumatic dilation, and botulinum toxin injection. Pneumatic dilation yields results that are generally better than botulinum toxin injection and may approach a clinical ...
Stavros N, Stavropoulos +2 more
openaire +2 more sources
Endoscopic therapy for achalasia is centered on disrupting or weakening the lower esophageal sphincter. The three traditional treatment options for achalasia are surgical myotomy, pneumatic dilation, and botulinum toxin injection. Pneumatic dilation yields results that are generally better than botulinum toxin injection and may approach a clinical ...
Stavros N, Stavropoulos +2 more
openaire +2 more sources